KML29
CAS: 1380424-42-9
Ref. 3D-FFC42442
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
KML29 is an amide compound that acts as a cannabinoid receptor agonist. It has been shown to be neuroprotective in in vitro experiments with cultured neurons and in vivo studies with rats injected with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to induce Parkinson's disease. KML29 also inhibits neuronal death induced by the fatty acid, arachidonic acid, and exhibits anti-cancer activity in a mouse model of prostate cancer. KML29 has been shown to have an effective dose at 1 mg/kg for striatal dopamine release and locomotor activity. The drug also binds to the GABAA receptor and shows efficacy against anxiety, depression, and seizures.
Propiedades químicas
Consulta técnica sobre: 3D-FFC42442 KML29
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
